Antimalarial drugs supplied by Scindia Pharma are utilized for treatment and prevention of malaria. These drugs focus on the erythrocytic stage of malaria infection, which is the level of infection resulting in symptomatic disease. The infection is produced by female mosquito bites. The medicines have good gametocidal properties that breaks gametocytes and contribute to the effective treatment of acute uncomplicated malaria diseases caused by Plasmodium falciparum. Antimalarial drugs fight against the infection in both children and adults. These are used only to treat and prevent malaria. Offered oral medicines are antiparasitic in nature and prevent nighttime leg pains.